Use stem cells, get sued

Dimitri Bonnville got cardiac stem cell therapy. Now he's suing

| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

When Dimitri Bonnville of Almont, Michigan, was shot in the chest with a nail gun by a construction coworker two years ago, the then 16-year-old eventually wound up at William Beaumont Hospital in Royal Oak, where James Robbins, a trauma surgeon, removed the three-inch-long spike from his right ventricle.

The procedure worked-at first. But the teenager soon suffered a major heart attack, prompting Beaumont physicians to suggest a radical-and, some say, unwarranted-step: They offered the boy an experimental stem cell transplant to rejuvenate his dead myocardium. Bonnville and his parents agreed, and he soon became the first cardiac stem cell recipient in the United States-a feat William Beaumont trumpeted in press releases that featured Bonnville and his family as willing participants.

Evidently, they've had a change of, er, heart. Earlier this year, the Bonnvilles filed suit against William Beaumont Hospital, Robbins, and Srinivas Dukkipati, the cardiology fellow who saw Bonnville ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Adam Marcus

    This person does not yet have a bio.

Published In

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

fujirebio-square-logo

Fujirebio Receives Marketing Clearance for Lumipulse® G pTau 217/ β-Amyloid 1-42 Plasma Ratio In-Vitro Diagnostic Test

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours